RTX-4-1-BBL

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameRTX-4-1-BBL
Drug Alias NameRTX-4-1-BBLRTX-4-1BBL
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor ligand superfamily member 9 Gene transferenceInterleukin-15 stimulants
TargetsTumor necrosis factor ligand superfamily member 9Interleukin-15
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRubius Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRubius Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A